Instituto de Investigação e Inovação em Saúde, Universidade do Porto
Rua Alfredo Allen, 208 4200-135 Porto, Portugal
Phone: +351 226 074 900
Email: info@i3s.up.pt
Immunology, Cancer & Glycomedicine
WHAT WE DO
Our Lab
Our group works at the interface of immunology, cancer and glycobiology, using a combination of in vitro, ex vivo and in vivo approaches.
Publications
The group’s research has been published in a number of high-impact publications over the years.
Research Topics
The group’s research explores several topics related to the impact of glycans on inflammation, autoimmunity and cancer.
OUR RESEARCH
OUR GROUP MAIN LINES OF RESEARCH:
Immune response
The exploitation of the cellular and molecular mechanisms by which glycans contribute to amplify immune response in chronic inflammation and autoimmunity.
OUR GROUP MAIN LINES OF RESEARCH:
Cancer glycosignatures
The investigation of how cancer-specific glycosignatures regulate the immunological networks in cancer.
HIGHLIGHTS
Pinho’s Lab distinguished by the Mizutani Foundation for Glycoscience
Pinho’s Lab has recently been distinguished by the Mizutani Foundation for Glycoscience, receiving funding for a groundbreaking research project dedicated to harnessing glycans to improve immunotherapies for colorectal cancer (CRC).
Pinho’s Lab PhD Students awarded with EFIS Travel Grants
Catarina Azevedo, Srishti Shah and Rafaela Nogueira – PhD students from Pinho’s lab – have recently been awarded with Travel Grants from the European Federation for Immunological Sciences (EFIS)!
New ICG article published in Gut Microbes on how mucosal glycans shape gut immunity in IBD
Our latest publication, published in the journal Gut Microbes, delves into how the glycosylation of the gut mucosa impacts the crosstalk between microbiota and immune cells in the context of inflammatory bowel disease (IBD).